ABC versus C-Rad Technology for Intrafraction Displacement and Dosimetric Impact in Breast Cancer Radiotherapy with Breath-Hold
While C-Rad optical surface monitoring offers significantly shorter treatment times than active breathing control (ABC) for breast cancer radiotherapy, it is associated with larger vertical intrafraction errors that increase with treatment duration, though both techniques result in only minor reductions in target coverage without significantly affecting doses to organs at risk.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Breast cancer remains the most common malignancy affecting women worldwide, and for many, the path to recovery involves a precise course of radiation therapy after surgery. The goal is to deliver a lethal dose to any remaining cancer cells while sparing the healthy organs nearby, particularly the heart and lungs. However, the human body is not a static statue; it breathes. This natural rhythm causes the chest wall and internal organs to shift up and down with every inhalation and exhalation. If a patient breathes normally during treatment, the radiation beam might miss the target or accidentally strike sensitive tissue. To solve this, doctors often ask patients to hold their breath during the beam's delivery, freezing the body in a stable position. This technique, known as breath-hold radiotherapy, has become a standard way to improve safety and accuracy, but the tools used to help patients hold their breath and ensure they stay still vary in how they work and how long the process takes.
Researchers at the Gansu Provincial Maternity and Child-Care Hospital in China recently set out to compare two different technologies used to manage this breath-holding process. On one side is a system called Active Breathing Control, which uses a mouthpiece and a nose clip to monitor the patient's airflow directly. On the other is a newer, non-invasive method called C-Rad, which uses a camera and structured light to project a pattern onto the patient's skin, tracking the movement of the chest surface without any physical contact. The team wanted to know which method was faster, which kept the patient steadier, and whether any tiny movements that did occur during treatment would change the dose of radiation the patient actually received. They enrolled thirty women who had recently undergone surgery for breast cancer, dividing them into two groups to receive treatment with one of these two systems.
The study revealed a clear trade-off between speed and precision. The group using the C-Rad camera system finished their daily treatment sessions faster, with a median time of about 7.44 minutes, compared to roughly 7.99 minutes for the group using the mouthpiece system. This difference, while seemingly small, adds up over the course of weeks of treatment and suggests that the camera-based method is more efficient for busy clinics. However, this speed came with a slight cost in stability. While both systems kept patients steady in the left-right and head-to-toe directions, the camera system allowed for slightly more movement in the vertical direction—the up-and-down motion of the chest. The researchers found that the vertical errors were significantly larger in the camera group, and these errors tended to grow as the treatment session dragged on. In fact, they identified a specific tipping point: if a single treatment session lasted longer than 10.93 minutes, the risk of the patient moving more than 2 millimeters vertically increased noticeably.
To understand what these tiny movements meant for the patient's health, the researchers ran computer simulations. They took the largest movement recorded for each patient and mathematically shifted the radiation plan to see how the dose would change if that error had actually happened. The results showed that for both groups, the most significant impact was a small reduction in the radiation dose hitting the target area, known as the planning target volume. In the mouthpiece group, the target dose dropped by a median of about 1.13 percent, while in the camera group, it dropped by a median of 2.90 percent. Crucially, the simulations showed that these movements did not lead to significant changes in the radiation dose received by the heart or the lungs. The errors were not large enough to cause a systematic increase in toxicity to these vital organs, though the slightly larger movements in the camera group did result in a slightly larger drop in target coverage.
Ultimately, the study suggests that neither technology is a perfect solution for every situation, and the choice depends on what matters most for the individual patient. The mouthpiece system offers superior control over vertical movement, keeping the target more precisely in place, but it requires a longer setup and treatment time. The camera system is faster and more comfortable for patients who cannot tolerate a mouthpiece, but it requires careful monitoring to ensure the session does not run too long, as longer times are linked to more vertical drift. The researchers concluded that while both methods are effective, clinicians should weigh the need for absolute positional precision against the benefits of a quicker, more comfortable treatment experience. For patients treated with the camera system, keeping the session under the 10-minute threshold appears to be a practical way to maintain the highest level of accuracy.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.